Magnetic resonance frequency shifts during acute MS lesion formation
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received August 9, 2012
- Accepted in final form April 4, 2013
- First Published June 12, 2013.
Article Versions
- Previous version (June 12, 2013 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Vanessa Wiggermann,
- Enedino Hernández Torres, PhD,
- Irene M. Vavasour, PhD,
- G.R. Wayne Moore, MD,
- Cornelia Laule, PhD,
- Alex L. MacKay, DPhil,
- David K.B. Li, MD,
- Anthony Traboulsee, MD and
- Alexander Rauscher, PhD
- Vanessa Wiggermann,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Enedino Hernández Torres, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Irene M. Vavasour, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) F. Hoffmann-la Roche Ltd. (2) TEVA Neuroscience
NONE
NONE
(1) Multiple Sclerosis Society of Canada
NONE
NONE
NONE
NONE
NONE
NONE
- G.R. Wayne Moore, MD,
Member of the Medical Advisory Committee of the Multiple Sclerosis Society of Canada
NONE
Teva: Honorarium for speaking at a neurology practicum in 2012.
NONE
NONE
NONE
NONE
Schering.
NONE
NONE
NONE
Berlex: Grant-in-aid of research.
NONE
NONE
Multiple Sclerosis Society of Canada
NONE
NONE
NONE
NONE
NONE
NONE
- Cornelia Laule, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
MS Society of Canada
NONE
NONE
NONE
NONE
NONE
NONE
- Alex L. MacKay, DPhil,
NONE
NONE
Cornell University, $1000 honorarium plus travel, Jan 2011 Washington University, $1000 honorarium plus travel, Nov 2011
NONE
NONE
NONE
University of British Columbia, Professor
NONE
NONE
NONE
NONE
Genzyme Corp, Advanced MRI measures of repair in Alemtuzimab treated patients, $35,000/yr, 2010-2014 Teva Innovation, Remyelination in multiple sclerosis, $46,000/yr, 2010-2014
NSERC, Proton Magnetic Resonance of Biological Systems, $60,000/yr, 2010-2015 MS Society of Canada, Anatomical and functional MRI correlates of cognitive dysfunction in multiple sclerosis, $92,000/yr, 2010-2014
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- David K.B. Li, MD,
Served on the Scientific Advisory Board Hoffmann-La Roche, Nuron Biotherapeutics and Data Safety Monitoring Board for Opexa Therapeutics
NONE
Consortium of MS Centers
NONE
NONE
NONE
NONE
Consultant to Genzyme
NONE
NONE
NONE
I am the Director of the UBC MS/MRI Research Group which has been contracted to perform central analysis of MRI scans for therapeutic trials with Angiotech, Bayer, Berlex-Schering, Bio-MS, Centocor, Daiichi Sankyo, Hoffmann-LaRoche, Merck-Serono, Schering-Plough, Teva Neurosciences, Sanofi-Aventis, Transition Therapeutics.
NONE
NONE
Grant support from MS Society of Canada, Canadian Institute of Health Research
NONE
NONE
NONE
NONE
NONE
NONE
- Anthony Traboulsee, MD and
1. Roche Clinical Trial Steering Committee (2010 ongoing) 2. Merck Serono Data Safety Monitoring Board (2009 ongoing) 3. Neuron Data Safety Monitoring Board (2013 ongoing) 4. MS Society of Canada Minocycline in CIS Clinical Trial Steering Committee (2009 ongoing)
NONE
1. Teva Neuroscience 2. Biogen 3. EMD Serono 4. Sanofi Genzyme 5. Novartis
NONE
NONE
NONE
NONE
Chugai Pharmaceuticals
NONE
NONE
NONE
1. Sanofi Genzyme 2. Roche 3. Bayer 4. Biogen
1. Canadian Institute for Health Research (PI)
NONE
1. MS Society of Canada 2. Lotte Hecht Foundation 3. Vancouver General and UBC Hospital Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Alexander Rauscher, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1. Canadian Institutes of Health Research (201109MSH-261306-183304) 2. National Sciences and Engineering Research Council (402039-2011)
NONE
NONE
NONE
NONE
NONE
NONE
- From the UBC MRI Research Centre (V.W., E.H.T., A.L.M., A.R.), Department of Radiology (V.W., E.H.T., I.M.V., C.L., A.L.M., D.K.B.L., A.R.), Department of Pathology & Laboratory Medicine (G.R.W.M., C.L.), International Collaboration for Repair Discoveries (G.R.W.M.), Department of Physics and Astronomy (A.L.M.), Brain Research Centre (A.L.M., D.K.B.L., A.T., A.R.), and Department of Medicine, Division of Neurology (A.T.), University of British Columbia, Vancouver, Canada.
- Correspondence to Dr. Rauscher: rauscher{at}physics.ubc.ca
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Increased diffusivity in acute multiple sclerosis lesions predicts risk of black holeR.T. Naismith, J. Xu, N.T. Tutlam et al.Neurology, May 24, 2010 -
Articles
Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosisG. L. Mancardi, F. Sardanelli, R. C. Parodi et al.Neurology, April 01, 1998 -
Articles
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MSD. H. Miller, D. Soon, K. T. Fernando et al.Neurology, April 23, 2007 -
Articles
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?Robert Zivadinov et al.Neurology, June 04, 2007